dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Calvo Barreiro, Laura |
dc.contributor.author | Eixarch Ahufinger, Herena |
dc.contributor.author | Boschert, Ursula |
dc.contributor.author | Espejo Ruiz, Carmen |
dc.contributor.author | Montalban Gairín, Xavier |
dc.contributor.author | Comabella Lopez, Manuel |
dc.contributor.author | Fissolo, Nicolás Miguel |
dc.date.accessioned | 2022-06-15T11:52:04Z |
dc.date.available | 2022-06-15T11:52:04Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Espejo C, Montalban X, et al. Immunomodulatory Effects Associated with Cladribine Treatment. Cells. 2021 Dec;10(12):3488. |
dc.identifier.issn | 2073-4409 |
dc.identifier.uri | https://hdl.handle.net/11351/7685 |
dc.description | Cladribina; Citometría de flujo; Esclerosis múltiple |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cells;10(12) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject | Resposta immunitària - Regulació |
dc.subject | Cèl·lules - Proliferació |
dc.subject.mesh | Multiple Sclerosis, Relapsing-Remitting |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Immunomodulation |
dc.subject.mesh | Cell Proliferation |
dc.title | Immunomodulatory Effects Associated with Cladribine Treatment |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cells10123488 |
dc.subject.decs | esclerosis múltiple recurrente-remitente |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inmunomodulación |
dc.subject.decs | proliferación celular |
dc.relation.publishversion | https://doi.org/10.3390/cells10123488 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fissolo N, Calvo-Barreiro L, Eixarch H, Espejo C, Montalban X, Comabella M] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Boschert U] Ares Trading, SA, 1262 Eysins, Switzerland. Merck KGaA, 64297 Darmstadt, Germany |
dc.identifier.pmid | 34943995 |
dc.identifier.wos | 000736151100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |